Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Balcer

Showing results (101-110 of 264) with videos related to

Pageof 27
Sort By:
Journal of the Neurological Sciences|March 31, 2004
Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessmentKelvin L Chou, Steven L Galetta, Grant T Liu, et al.
Journal of the Neurological Sciences|April 24, 2012
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MSLaura J Balcer, Steven L Galetta, Chris H Polman, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 17, 2024
MICK (Mobile Integrated Cognitive Kit) App for Concussion Assessment in a Youth Ice Hockey LeagueSara Hyman, Mason Blacker, Carter A Bell, et al.
Neurology. Clinical Practice|September 11, 2025
Faculty Perspectives on Appreciation Strategies in a Neurology DepartmentSara W Hyman, Daniel N de Souza, Laura J Balcer, et al.
American Journal of Ophthalmology|May 7, 2002
Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaireSiu-Ling Ma, Judy A Shea, Steven L Galetta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2015
Outer retinal changes following acute optic neuritisOmar A Al-Louzi, Pavan Bhargava, Scott D Newsome, et al.
CNS Drugs|February 13, 2023
Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label StudyJai Perumal, Roumen Balabanov, Ray Su, et al.
Ophthalmology|May 11, 2020
Neuro-ophthalmology in the Era of COVID-19: Future Implications of a Public Health CrisisScott N Grossman, Rachel Calix, Sharon Tow, et al.
CNS Drugs|September 6, 2022
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label StudyJai Perumal, Roumen Balabanov, Ray Su, et al.
Eneurologicalsci|February 19, 2021
Sleep-deprived residents and rapid picture naming performance using the Mobile Universal Lexicon Evaluation System (MULES) testJenna Conway, Luke Moretti, Rachel Nolan-Kenney, et al.
Pageof 27

Showing results (101-110 of 264) with videos related to

Sort By:
Pageof 27
Journal of the Neurological Sciences|March 31, 2004
Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessmentKelvin L Chou, Steven L Galetta, Grant T Liu, et al.
Journal of the Neurological Sciences|April 24, 2012
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MSLaura J Balcer, Steven L Galetta, Chris H Polman, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 17, 2024
MICK (Mobile Integrated Cognitive Kit) App for Concussion Assessment in a Youth Ice Hockey LeagueSara Hyman, Mason Blacker, Carter A Bell, et al.
Neurology. Clinical Practice|September 11, 2025
Faculty Perspectives on Appreciation Strategies in a Neurology DepartmentSara W Hyman, Daniel N de Souza, Laura J Balcer, et al.
American Journal of Ophthalmology|May 7, 2002
Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaireSiu-Ling Ma, Judy A Shea, Steven L Galetta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2015
Outer retinal changes following acute optic neuritisOmar A Al-Louzi, Pavan Bhargava, Scott D Newsome, et al.
CNS Drugs|February 13, 2023
Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label StudyJai Perumal, Roumen Balabanov, Ray Su, et al.
Ophthalmology|May 11, 2020
Neuro-ophthalmology in the Era of COVID-19: Future Implications of a Public Health CrisisScott N Grossman, Rachel Calix, Sharon Tow, et al.
CNS Drugs|September 6, 2022
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label StudyJai Perumal, Roumen Balabanov, Ray Su, et al.
Eneurologicalsci|February 19, 2021
Sleep-deprived residents and rapid picture naming performance using the Mobile Universal Lexicon Evaluation System (MULES) testJenna Conway, Luke Moretti, Rachel Nolan-Kenney, et al.
Pageof 27